Prostate cancer: Cardiovascular risk and androgen deprivation therapy

RazzakM.

首页> 外文期刊>Nature reviews. Urology >Prostate cancer: Cardiovascular risk and androgen deprivation therapy

【24h】

Prostate cancer: Cardiovascular risk and androgen deprivation therapy

机译：前列腺癌：心血管风险和雄激素剥夺治疗

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Two papers recently published in Andrologia further elucidate the effects of reactive oxygen species (ROS) and antioxidants on sperm parameters and fertilization. The findings of both studies support the assessment of ROS levels in the semen and cervical mucus of infertile couples under etiological evaluation.

机译：最近在《 Andrologia》上发表的两篇论文进一步阐明了活性氧（ROS）和抗氧化剂对精子参数和受精的影响。两项研究的结果均支持根据病因学评估不育夫妇精液和宫颈粘液中的ROS水平。

著录项

来源
《Nature reviews. Urology》 |2012年第2期|共1页
作者
RazzakM.;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类泌尿科学（泌尿生殖系疾病）;
关键词

相似文献

外文文献
中文文献
专利

1. Reply from Authors re: Ronald C. Chen. Decisions Regarding Whether to Use Androgen Deprivation Therapy with Radiotherapy in Prostate Cancer: Is Cardiovascular Mortality the Most Relevant Outcome? Eur Urol 2016;69:211-2 Outcomes for Favorable and Unfavorable Intermediate Risk Prostate Cancer Patients Receiving Radiation Therapy With or Without Short-term Androgen Deprivation Therapy [J] . Voog Justin C., Paulus Rebecca, Efstathiou Jason A. European urology . 2016,第2期

机译：作者的回复：Ronald C. Chen。关于是否在前列腺癌中使用雄激素剥夺疗法和放射疗法的决定：心血管疾病死亡率是最相关的结果吗？ Eur Urol 2016; 69：211-2接受或不接受短期雄激素剥夺疗法的放射治疗的中危险前列腺癌患者的有利和不利结果
2. A meta-analysis of cardiovascular events in intermittent androgen-deprivation therapy versus continuous androgen-deprivation therapy for prostate cancer patients [J] . C Jin, Y Fan, Y Meng, Prostate Cancer and Prostatic Diseases . 2016,第4期

机译：对前列腺癌患者间歇性雄激素剥夺治疗与连续雄激素剥夺治疗中心血管事件的荟萃分析
3. Reply from Authors re: Ramdev Konijeti, Adam S. Kibel. Androgen deprivation therapy for localized and nonmetastatic prostate cancer: Too much of a good thing? Eur Urol 2012;61:1129-30: Still much to understand about androgen deprivation therapy and cardiovascular disease [J] . KeatingN.L., SmithM.R., HuJ.C. European urology . 2012,第6期

机译：作者的回复：Ramdev Konijeti，Adam S. Kibel。局部和非转移性前列腺癌的雄激素剥夺疗法：太好了吗？ Eur Urol 2012; 61：1129-30：对雄激素剥夺疗法和心血管疾病还有很多了解
4. Serum levels of sex hormones before and after androgen deprivation therapy in Japanese prostate cancer patients [C] . A. Komiya, K. Ichimatsu, A. Morii, International Congress of Andrology . 2009

机译：日本前列腺癌患者中雄激素剥夺治疗前后的性激素血清水平
5. Risk for Cardiovascular Diseases in Prostate Cancer Patients Treated with Androgen Deprivation: A Population-based Cohort Study [D] . Jiang, Lei. 2018

机译：治疗雄激素剥夺治疗前列腺癌患者心血管疾病的风险：基于人群的群组研究
6. Cardiovascular Risks of Androgen Deprivation Therapy for Prostate Cancer [O] . Giovanni Corona, Sandra Filippi, Nicola Bianchi, 2021

机译：前列腺癌雄激素剥夺治疗的心血管风险
7. Erratum: A meta-analysis of cardiovascular events in intermittent androgen-deprivation therapy versus continuous androgen-deprivation therapy for prostate cancer patients [O] . C Jin, Y Fan, Y Meng, 2016

机译：错误：间歇性雄激素剥夺治疗中心血管事件的荟萃分析与前列腺癌患者的连续腺剥夺治疗

Prostate cancer: Cardiovascular risk and androgen deprivation therapy

摘要

著录项

相似文献

相关主题

期刊订阅